Austar Lifesciences Limited 6118 2020 12 31 2020 2019 1,295,980 1,049,021 323,530 284,244 41,489 12,208 33,100 8,091 1,378,844 1,174,322 524,574 502,625 25.0% 27.1% 1.4 1.5 12.7% 10.2% 0.06 0.02 0.06 0.02 2020 2019 12 31 2020 2019 12 31 1
2020 12 31 2019 12 31 2020 2019 12 31 12 31 3 1,295,980 1,049,021 6 (972,450) (764,777) 323,530 284,244 6 (148,692) (137,077) 6 (98,695) (108,731) (12,139) (5,109) 6 (48,268) (42,577) 8,039 9,153 5 6,955 146 30,730 49 4 3,115 5,703 4 (2,833) (3,736) 282 1,967 10,477 10,192 41,489 12,208 8 (9,884) (4,744) 31,605 7,464 33,100 8,091 (1,495) (627) 2
2020 2019 12 31 12 31 31,605 7,464 (10,441) 5,713 74 55 711 (213) (9,656) 5,555 21,949 13,019 23,362 13,573 (1,413) (554) 21,949 13,019 9 0.06 0.02 3
2020 2019 12 31 12 31 68,625 55,005 117,300 90,426 23,459 26,253 7,047 6,558 62,940 57,509 10,190 10,399 289,561 246,150 209,240 163,517 12 238,119 185,747 11 279,417 251,091 56,469 47,746 127,927 88,778 162 209 177,949 191,084 1,089,283 928,172 1,378,844 1,174,322 4,071 4,071 379,822 389,560 134,006 100,906 517,899 494,537 6,675 8,088 524,574 502,625 4
2020 2019 12 31 12 31 32,337 24,988 452 1,972 15,797 10,950 48,586 37,910 13 439,957 378,708 12 322,177 222,276 832 907 14 30,000 20,000 12,718 11,896 805,684 633,787 854,270 671,697 1,378,844 1,174,322 5
2020 12 31 1. 2014 1 9 22 1961 3 Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands Standard Fortune Holdings Limited 0.01 2014 11 7 2021 3 26 2. 622 6
(a) 2020 1 1 1 8 3 7 9 39 (b) 2020 12 31 3. (1) (2) (3) (4) GMP (5)(6) 7
2020 12 31 GMP 634,619 303,465 120,822 55,595 254,508 20,800 1,389,809 (46,131) (39,029) (297) (2,866) (4,338) (1,168) (93,829) 588,488 264,436 120,525 52,729 250,170 19,632 1,295,980 139,202 42,855 13,741 2,162 250,170 19,632 467,762 449,286 221,581 106,784 50,567 828,218 (498,237) (207,239) (86,414) (26,754) (140,819) (12,987) (972,450) 90,251 57,197 34,111 25,975 109,351 6,645 323,530 2,715 704 54 23 9 3,505 16,729 5,957 1,435 801 3,066 407 28,395 7,670 1,899 783 357 1,293 137 12,139 (818) 1,021 518 218 (533) 70 476 3,141 3,141 7,559 123 2,795 10,477 8
2019 12 31 GMP 482,816 300,934 87,175 54,685 204,303 24,056 1,153,969 (46,836) (50,059) (4,212) (1,044) (717) (2,080) (104,948) 435,980 250,875 82,963 53,641 203,586 21,976 1,049,021 82,829 55,871 31,572 8,468 203,586 21,976 404,302 353,151 195,004 51,391 45,173 644,719 (361,347) (191,980) (55,048) (25,525) (116,941) (13,936) (764,777) 74,633 58,895 27,915 28,116 86,645 8,040 284,244 1,536 632 58 33 15 2,274 13,434 6,338 1,119 698 2,141 293 24,023 4,872 (263) (191) (79) 819 (49) 5,109 11,902 1,018 165 104 344 43 13,576 5,222 (208) 5,178 10,192 9
2020 2019 12 31 12 31 90,251 74,633 57,197 58,895 34,111 27,915 GMP 25,975 28,116 109,351 86,645 6,645 8,040 323,530 284,244 (148,692) (137,077) (98,695) (108,731) (12,139) (5,109) (48,268) (42,577) 8,039 9,153 6,955 146 282 1,967 10,477 10,192 41,489 12,208 10
2020 2019 12 31 2020 12 31 2019 12 31 543,838 17,758 354,973 17,369 255,687 23,010 255,540 21,517 71,943 70,490 GMP 33,197 32,586 159,687 22,172 136,658 18,623 6,745 28,085 1,071,097 62,940 878,332 57,509 7,047 6,558 300,700 289,432 1,378,844 1,174,322 11
2020 2019 12 31 12 31 1,219,015 964,135 76,965 84,886 1,295,980 1,049,021 2020 2019 12 31 12 31 192,213 152,502 80,111 76,691 272,324 229,193 12
4. 2020 2019 12 31 12 31 (1,038) (1,739) (1,755) (1,610) (40) (387) (2,833) (3,736) 2,624 5,194 PALL-AUSTAR Lifesciences Limited PALL-AUSTAR JV 491 509 3,115 5,703 282 1,967 5. 2020 2019 12 31 12 31 (47) (218) 4,396 (2,415) 2,606 2,779 6,955 146 13
6. 2020 2019 12 31 12 31 722,907 570,889 7 308,833 225,741 48,225 59,659 33,676 43,136 12,681 22,176 22,796 21,973 476 13,576 12,319 13,310 12,005 11,176 16,390 12,847 7,233 10,524 8,663 6,548 8,180 4,988 3,991 3,988 724 9 3,505 2,274 3,141 2,560 1,997 9,768 1,526 8,535 8,316 2,618 1,369 1,873 2,855 1,818 2,028 1,423 2,805 1,306 1,076 676 603 562 995 11,221 6,778 1,268,105 1,053,162 14
7. 2020 2019 12 31 12 31 277,392 177,499 31,441 48,242 308,833 225,741 8. 2020 2019 12 31 12 31 5,571 2,903 4,313 1,841 9,884 4,744 16.5% 2019 16.5% 30% 2019 30% 15
25% 15% 2014 2018 20132019 2020 12 31 20% 50% 9. (a) 2020 2019 12 31 12 31 33,100 8,091 512,582 512,582 0.06 0.02 (b) 2020 2019 12 31 2020 2019 12 31 16
10. 2020 12 31 2019 11. 2020 2019 12 31 12 31 (b) 265,311 226,963 (a) 46,462 47,116 311,773 274,079 (32,356) (22,988) 279,417 251,091 (a) 2019 (b) 2020 2019 12 31 12 31 6 165,784 143,827 6 1 20,817 17,536 1 2 41,513 29,576 2 3 10,594 26,767 3 26,603 9,257 265,311 226,963 90 17
12. 2020 2019 12 31 12 31 240,778 186,523 (4,699) (3,659) 236,079 182,864 2,040 2,883 238,119 185,747 (322,177) (222,276) 13. 2020 2019 12 31 12 31 280,591 236,504 16,331 25,244 64,499 37,856 15,067 3,510 12,109 12,422 17,401 29,883 3,494 5,533 1,410 1,563 29,055 26,193 439,957 378,708 18
2020 2019 12 31 12 31 6 247,112 206,632 6 1 12,667 14,597 1 2 13,036 7,550 2 3 2,146 2,735 3 5,630 4,990 280,591 236,504 14. 2020 2019 12 31 12 31 (a) 20,000 20,000 (b) 10,000 30,000 20,000 (a) 2020 12 31 2020 12 31 4.57% 2019 4.57% (b) 2020 12 31 2020 12 31 3.65%2019 19
2019 COVID-19 2020 2021 licensein license-out 2020 MAH MAH GEP CQV TTM 20
MAH CMO PQS TTM PD-1 CDMO CFDI 2020 COVID-19 CMO CDMO CRO MAH 2020 12 10 CAPEX 21
COVID-19 2020 1.5 2 2019 29.4% 23.5% BSL-3 COVID-19 22
12 31 2020 2019 % % % 878,656 47.3% 607,398 42.3% 44.7% 435,866 23.5% 330,727 23.0% 31.8% 152,409 8.2% 118,418 8.3% 28.7% GMP 46,818 2.5% 89,284 6.2% (47.6%) 323,153 17.4% 267,527 18.6% 20.8% 20,964 1.1% 22,512 1.6% (6.9%) 1,857,866 100.0% 1,435,866 100.0% 29.4% 1,857.9 2019 12 31 1,435.9 29.4% GMP 2020 2 3 23
878.7 2019 12 31 607.4 271.3 44.7% COVID-19 24
435.9 2019 12 31 330.7 105.1 31.8% IT 2019 12 31 118.4 34.0 28.7% 152.4 2020 GMP GMP GMP COVID-19 GMP 2019 12 31 89.3 42.5 47.6% 46.8 GMP 25
2019 12 31 267.5 55.6 20.8% 323.2 COVID-19 2019 12 31 22.5 1.5 6.9% 21.0 2020 12 31 2020 12 31 % % 383 36.8% 619,552 49.9% 238 22.9% 399,672 32.2% 103 9.9% 102,986 8.3% GMP 108 10.4% 63,556 5.1% 208 20.0% 56,284 4.5% 1,040 100.0% 1,242,050 100.0% 26
AUSTAR UK Limited 2020 2021 2 ISO9001 COVID-19 H+E Pharma GmbH H+E Pharma S-Tec GmbH 2021 31,200 2022 7 5 2020 27
APS COVID-19 639 344 2019 35% COVID-19 10 COVID-19 BSL-3 CNAS BSL-3 BIM 2020 FAT 28
2020 3 2020 COVID-19 2020 2020 9 CIPM Medtec Analytica AUSTAR 12 2020 2 2020 2020 10 COVID-19 115 12 29
2020Facebook Twitter Instagram LinkedIn 2020 11 2020 12 31 269 44 99 Werum Rockwell 30
AUSTAR AUSTAR Smart Interconnection SMS (Thermo Fisher) (REMOIIS) (OSD) AUSTAR UK Limited (API) AusMill API (PAT) BSL-3 COVID-19 2020 BSL-3 (CFD) BSL-3 31
2021 2020 12 2020 / (HVAC)/ (EMS)/ (BMS) COVID-19 2022 32
2020 COVID-19 2020 CRO CDMO CMO CDMO CDMO OSD 33
COVID-19 BSL-3 BSL-3 OSD 2021 CDMO 2020 1 Net-Pharma OSD HVAC (GEP) 34
REMOIIS 2020 + GMP GMP AMTP CRO CDMO GMP GMP CDMO CMO GMP CRO GMP GMP CQV PQS GEP TTM CQV PQS TTM GEP CQV 35
GMP PQS MAH irisk COVID-19 GMP GMPCQV PQS GEP COVID-19 GMP GMP 36
(1) (2) (3) (4)GMP (5) (6) 1,296.0 201923.5% GMP 2020 2019 12 31 12 31 2020 2019 % % % 588,488 45.4% 435,980 41.6% 35.0% 264,436 20.4% 250,875 23.9% 5.4% 120,525 9.3% 82,963 7.9% 45.3% GMP 52,729 4.1% 53,641 5.1% (1.7%) 250,170 19.3% 203,586 19.4% 22.9% 19,632 1.5% 21,976 2.1% (10.7%) 1,295,980 100.0% 1,049,021 100.0% 23.5% 37
2019 12 31 436.0 152.5 35.0% 588.5 2019 12 31 H+E Pharma COVID-19 2019 12 31 250.9 13.6 5.4% 264.4 2019 12 31 2019 12 31 83.037.645.3% 120.5 2019 12 31 GMP GMP 2019 12 31 53.60.91.7% 52.7 COVID-19 GMP 38
2019 12 31 203.6 46.622.9% 250.2 COVID-19 2019 12 31 22.0 2.3 10.7% 19.6 2020 2019 12 31 12 31 2020 2019 % % % 1,219,015 94.1% 964,135 91.9% 26.4% 76,965 5.9% 84,886 8.1% (9.3%) 1,295,980 100.0% 1,049,021 100.0% 23.5% 94.1% 2019 91.9% 2019 12 31 764.8 207.7 27.2% 972.5 39
2019 12 31 284.2 39.3 13.8% 323.5 GMP 2019 12 31 27.1% 25.0% 12 31 2020 2019 % % % % 90,251 27.9% 15.3% 74,633 26.3% 17.1% 57,197 17.7% 21.6% 58,895 20.7% 23.5% 34,111 10.5% 28.3% 27,915 9.8% 33.6% GMP 25,975 8.0% 49.3% 28,116 9.9% 52.4% 109,351 33.8% 43.7% 86,645 30.5% 42.6% 6,645 2.1% 33.8% 8,040 2.8% 36.6% 323,530 100.0% 25.0% 284,244 100.0% 27.1% 1. 2. 40
2019 12 31 74.6 15.6 20.9% 90.3 2019 12 31 17.1% 15.3% COVID-19 2019 12 31 58.9 1.7 2.9% 57.2 2019 12 31 23.5% 21.6% LEAN 2019 12 31 27.9 6.222.2% 34.1 2019 12 31 33.6% 28.3% 41
GMP GMP 2019 12 31 28.1 2.1 7.6% 26.0 GMP 2019 12 31 52.4% 49.3% COVID-19 2019 12 31 86.622.726.2% 109.4 2019 12 31 42.6% 43.7% 2019 12 31 8.0 1.4 17.4% 6.6 2019 12 31 36.6% 33.8% COVID-19 2019 12 31 9.2 1.1 12.2% 8.0 42
2019 12 31 0.1 6.8 7.0 4.4 2019 12 31 2.4 2019 12 31 137.1 11.6 8.5% 148.7 28.2 2.1 9.49.6 2019 12 31 108.7 10.09.2% 98.7 13.1 3.1 H+E Pharma, COVID-19 2020 12 31 473.3% 2019 12 31 42.6 5.7 13.4% 48.3 4.9 43
2019 12 31 2.0 0.3 2.6 0.9 2019 12 31 10.2 0.3 10.5 STERIS-AUSTAR Pharmaceutical Systems Hong Kong Limited STERIS-AUSTAR JV ROTA Verpackungstechnik GmbH & Co. KG and ROTA Verpackungstechnik Verwaltungsgesellschaft mbh 2.3 0.3 PALL-AUSTAR JV 2.4 PALL-AUSTAR JV 5.5 2019 12 31 12.2 29.3 41.5 2019 12 31 4.7 5.1 9.9 29.3 2019 12 31 7.5 24.1 31.6 44
12 31 2020 2019 52,224 37,793 (59,806) (22,087) (5,513) (20,694) (13,095) (4,988) 52.2 i. 41.5 12.0 16.4 12.1 3.5 3.1 10.5 1.8 ii. 99.9 61.0 iii. 39.1 54.4 47.3 41.7 59.8 i. 39.3 ii. 27.9 iii. STERIS-AUSTAR JV 7.1 45
5.5 35.0 12.6 2.8 45.0 2020 12 31 2019 12 31 177.9 191.1 127.9 88.8 2020 12 31 2019 12 31 294.4 10.8 2020 12 31 283.6 2020 12 31 1,089.3 2019 12 31 928.2 161.1 i. 52.4 45.7 39.1 28.3 8.7 ii. 13.1 2020 12 31 805.7 2019 12 31 633.8 171.9 99.9 61.2 10.0 0.8 0.1 46
2020 12 31 30.0 10.0 20.0 4.57% (2019 4.57%) 10.0 3.65% (2019 ) 2020 12 31 12.7% 2019 12 31 10.2% 100% 2020 12 31 127.9 5.6 5.22019 12 31 6.4 5.4 20.0 2019 12 31 20.0 2020 12 31 2019 12 31 2020 12 31 1,404 2019 12 31 92 308.8 2019 12 31 225.7 36.8% 47
2020 12 31 105.0 48
2014 1 9 2014 11 7 IPO IPO 411.8 2014 10 28 2020 12 31 2020 12 31 2020 12 31 39.6% 163.1 126.7 78.5 49.5 84.6 77.2 1 14.2% 58.4 45.4 47.4 36.2 11.0 9.2 2 6.8% 28.0 21.8 28.0 21.8 9.5% 39.1 30.4 39.1 30.4 20% 82.4 64.0 44.7 29.6 37.7 34.4 9.9% 40.8 31.7 40.8 31.7 100.0% 411.8 320.0 278.5 199.2 133.3 120.8 49
1. 126.7 163.1 77.2 84.6 2021 2. 45.4 58.4 2020 10 23 2021 9.211.0 2021 204.3 2020 12 31 133.3 50
2021 2 11 PALL- AUSTAR Lifesciences Limited 40% PALL-AUSTAR JV PALL-AUSTAR JV 60% 34,500,000 PALL-AUSTAR JV 2019 2021 5 28 2021 2021 5 25 2021 5 28 2021 2021 5 24 183 54 51
A.2.1 A.2.1 52
2014 10 21 3.21 3.23 2020 12 31 2020 12 31 (www.hkexnews.hk) (www.austar.com.hk) 53
2021 3 26 54